Epidemiology of comorbid substance use and psychiatric disorders in Asia

Current Opinion in Psychiatry

Volumn 25, Issue 3, 2012, Pages 172-180

  Thirthalli, Jagadisha ^a   Kumar, Channaveerachari Naveen ^a   Arunachal, Gautham ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

comorbidity; psychiatric disorders; substance use disorders

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; OPIATE;

ADJUSTMENT DISORDER; ALCOHOLISM; ANXIETY DISORDER; ASIA; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CANNABIS ADDICTION; COCAINE DEPENDENCE; COMORBIDITY; HEROIN DEPENDENCE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; MULTICENTER STUDY (TOPIC); OPIATE ADDICTION; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SMOKING; SOCIAL STATUS; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ASIA; COMORBIDITY; HUMANS; MENTAL DISORDERS; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 84859359804     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3283523c26     Document Type: Review

References (47)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511-2518.
2. Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010; 105:1117-1128.
3. Najt P, Fusar-Poli P, Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychatry Res 2011; 186:159-164.
4. Davis L, Uezato A, Newell JM, Frazier E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry 2008; 21:14-18. (Pubitemid 351339802)
5. Deas D, Brown ES. Adolescent substance abuse and psychiatric comorbidities. J Clin Psychiatry 2006; 67:18-23. (Pubitemid 44378995)
6. Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37:11-24.
7. Volkow ND. Substance use disorders in schizophrenia-clinical implications of comorbidity. Schizophr Bull 2009; 35:469-472.
8. Boden JM, Fergusson DM. Alcohol and depression. Addiction 2011; 106:906-914.
9. Tominaga M, Kawakami N, Ono Y, et al. Prevalence and correlates of illicit and nonmedical use of psychotropic drugs in Japan: findings from the World Mental Health Japan Survey 2002-2004. Soc Psychiatry Psychiatr Epidemiol 2009; 44:777-783.
10. Merikangas KR, Mehta RL, Molnar BE, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International consortium in Psychiatric Epidemiology. Addict Behav 1998; 23:893-907. (Pubitemid 28443200)
11. World Health Organization. Composite International Diagnostic Interview (CIDI). Geneva: World Health Organization; 1993.
12. Caspi Y, Saroff O, Suleimani N, Klein E. Trauma exposure and post traumatic reactions in a community sample of Bedouin members of the Israel Defense Forces. Depress Anxiety 2008; 25:700-707.
13. Chiang SC, Chan HY, Chang YY, et al. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry Clin Neurosci 2007; 61:105-111.
14. Huang MC, Yu CH, Chen CT, et al. Prevalence and identification of alcohol use disorders among severe mental illness inpatients in Taiwan. Psychiatry Clin Neurosci 2009; 63:94-100.
15. Katz G, Durst R, Shuman E, et al. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients. Compr Psychiatry 2010; 51:37-41.
16. Kim KW, Choi EA, Lee SB, et al. Prevalence and neuropsychiatric comorbidities of alcohol use disorders in an elderly Korean population. Int J Geriatr Psychiatry 2009; 24:1420-1428.
17. Koyama A, Miyake Y, Kawakami N, et al. Life time prevalence, psychiatric comorbidity and demographic correlates of 'Hikikomori' in a community population in Japan. Psychiatry Res 2010; 176:69-74.
18. Lam AKS, Ho TP. Early adolescent outcome of attention-deficit hyperactivity disorder in a Chinese population: 5-year follow-up study. Hong Kong Med J 2010; 16:257-264.
19. Liu IC, Chiu CH, Yang TT, et al. The effects of gender and a co-occurring depressive disorder on neurocognitive functioning in patients with alcohol dependence. Alcohol Alcohol 2010; 45:231-236.
20. Ma X, Xiang YT, Cai ZJ, et al. Smoking and psychiatric disorders in the rural and urban regions of Beijing, China: a community based survey. Drug Alcohol Depend 2009; 100:146-152.
21. Orui M, Kawakami N, Iwata N, et al. Lifetime prevalence of mental disorders and its relationship to suicidal ideation in a Japanese rural community with high suicide and alcohol consumption rates. Environ Health Prev Med 2011; 16:384-389.
22. Park S, Cho MJ, Chang SM, et al. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study. Psychiatry Res 2011; 186:378-383.
23. Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord 2007; 99:213-220. (Pubitemid 46275039)
24. Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 2009; 373:2041-2053.
25. Shinozaki Y, Nakao M, Takeuchi T. Smoking rates among schizophrenia patients in Japan. Psychiatry Res 2011; 186:165-169.
26. Tang YL, George TP, Mao PX, et al. Cigarette smoking in Chinese male inpatients with schizophrenia: a cross-sectional analysis. J Psychiatr Res 2007; 41:43-48. (Pubitemid 44708205)
27. Wang CY, Xiang YT, Weng YZ, et al. Cigarette smoking in patients with schizophrenia in China: prospective multicentre study. Aust N Z J Psychiatry 2010; 44:456-462.
28. Yoshimasu K, Kawakami N, WMH-J 2002-2006 Survey Group. Epidemiological aspects of intermittent explosive disorder in Japan; prevalence and psychosocial comorbidity: findings from the World Mental Health Japan Survey 2002-2006. Psychiatry Res 2011; 186:384-389.
29. Zhang XY, Zhang RL, Pan M, et al. Sex difference in the prevalence of smoking in Chinese schizophrenia. J Psychiatr Res 2010; 44:986-988.
30. Biederman J, Wilens T, Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997; 36:21-29. (Pubitemid 27024224)
31. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990; 29:546-557. (Pubitemid 20235340)
32. Kessler RC, Coccaro EF, Fava M, et al. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63:669-678. (Pubitemid 43848298)
33. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59:22-33. (Pubitemid 29001829)
34. Chand PK, Murthy P, Thirthalli J. Prevalence of substance use among first episode psychosis patients using self-report and urine analysis. 8 October 2011. In 2nd International Congress Dual Disorders, Addictive Behaviors and Other Mental Disorders 5-8 October 2011, Barcelona, Spain.
35. Thirthalli J, Venkatesh BK, Gangadhar BN. Psychoses and illicit drug use: need for cross-cultural studies. Acta Psychiatr Scand 2008; 118:86. (Pubitemid 351832024)
36. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV-TR axis I disorders. New York: Biometrics Research Department, New York State Psychiatric Institute; 2002.
37. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption: II. Addiction 1993; 88:791-804. (Pubitemid 23194530)
38. Yen CF, Chen CC, Cheng CP, et al. Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder. Psychiatry Clin Neurosci 2008; 62:685-690.
39. Cantor-Graae E, Nordström LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001; 48:69-82. (Pubitemid 32241184)
40. Lin CC, Bai YM, Hu PG, Yeh HS. Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital. Gen Hosp Psychiatry 1998; 20:98-101.
41. Tsai SY, Chen CC, Yeh EK. Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder. J Affect Disord 1997; 46:143-150.
42. Carey KB, Carey MP, Chandra PS. Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India. J Clin Psychiatry 2003; 64:767-774. (Pubitemid 36897212)
43. De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76:135-157. (Pubitemid 40812332)
44. Srinivasan TN, Thara R. Smoking in schizophrenia: all is not biological. Schizophr Res 2002; 56:67-74. (Pubitemid 34655469)
45. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944. (Pubitemid 14076461)
46. Chen CC, Tsai SY, Su LW, et al. Psychiatric co-morbidity among male heroin addicts: differences between hospital and incarcerated subjects in Taiwan. Addiction 1999; 94:825-832.
47. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand 1989; 79:136-147.